|
ATXN10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.024480E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.4105000000072E-05 |
| Normal-vs-Stage2 |
2.138300E-03 |
| Normal-vs-Stage3 |
4.558000E-03 |
| Normal-vs-Stage4 |
5.223100E-04 |
| Stage1-vs-Stage2 |
7.084600E-01 |
| Stage1-vs-Stage3 |
6.467800E-01 |
| Stage1-vs-Stage4 |
8.023600E-01 |
| Stage2-vs-Stage3 |
9.068400E-01 |
| Stage2-vs-Stage4 |
5.983400E-01 |
| Stage3-vs-Stage4 |
5.480600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.27609999975998E-07 |
| Normal-vs-AfricanAmerican |
4.28300000000492E-05 |
| Normal-vs-Asian |
2.548500E-02 |
| Caucasian-vs-AfricanAmerican |
3.352000E-01 |
| Caucasian-vs-Asian |
5.503000E-01 |
| AfricanAmerican-vs-Asian |
6.828400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15939999999026E-05 |
| Normal-vs-Female |
6.955700E-03 |
| Male-vs-Female |
2.403300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.09110000000723E-05 |
| Normal-vs-Extreme_Weight |
1.71391999999049E-05 |
| Normal-vs-Obese |
9.848500E-04 |
| Normal-vs-Extreme_Obese |
4.118800E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.403800E-01 |
| Normal_Weight-vs-Obese |
2.055600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.448800E-01 |
| Extreme_Weight-vs-Obese |
3.557900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.769400E-01 |
| Obese-vs-Extreme_Obese |
2.370200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.534570E-01 |
| Normal-vs-Age(41-60Yrs) |
1.239900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.84640000014491E-07 |
| Normal-vs-Age(81-100Yrs) |
3.79500000000643E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.663000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.236400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.416400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.131600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.416600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.317200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.64919999999481E-05 |
| Normal-VS-Type2 PRCC |
4.65019999951188E-07 |
| Normal-VS-KIRP CIMP |
8.061400E-01 |
| Normal-VS-Unclassified PRCC |
2.399800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.663040E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.047980E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.676400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.953600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.708000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.074610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83961999999926E-05 |
| Normal-vs-N1 |
2.537500E-02 |
| Normal-vs-N2 |
1.210840E-01 |
| N0-vs-N1 |
1.378590E-01 |
| N0-vs-N2 |
6.792200E-01 |
| N1-vs-N2 |
6.988800E-01 |
|
|
